Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, trichoscopy was used to diagnose female androgenic alopecia with 92% specificity by identifying specific hair and scalp patterns.

Malnutrition can cause unusual eyelash growth and hair loss.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

This comment discusses the use of 'follicular Swiss cheese' as a diagnostic feature for alopecia areata and does not report new clinical findings.

This study found that inadequate ferritin levels, rather than haemoglobin levels, indicated iron deficiency in women with telogen effluvium, alopecia areata, and female pattern hair loss.

This case study identified low iron stores, potentially linked to heavy menstrual periods, as a trigger for diffuse nonscarring alopecia in a 31-year-old woman, leading to a diagnosis of telogen effluvium, for which iron supplementation was prescribed.

This study found that lower vitamin D levels were inversely associated with the severity of female pattern hair loss and patchy alopecia areata, but not with telogen effluvium.

This review discusses the potential impact of lifestyle factors on the progression of androgenetic alopecia and reports no new clinical findings; the authors emphasize the need for more comprehensive studies.

This study found that combining fractional laser therapy, intravenous blood irradiation, and minoxidil significantly improved the psycho-emotional state and quality of life in patients with diffuse telogen effluvium, performing better than individual treatments alone, as measured by the DIQOL index.

This study found that vitamin D levels were lower in alopecia areata patients, with trichoscopic features like broken hairs and black dots more prevalent in cases with vitamin D deficiency.

In this survey of dermatologists in India, most participants reported that nutritional deficiencies are common in alopecia patients and preferred using serum peptide formulations, rating them as "very good" or "good" for efficacy, with Folliserum receiving high marks for aesthetics.

This paper reviews alopecia areata incognita, a condition causing diffuse hair loss without typical patches, and highlights the need for scalp biopsy for diagnosis, but reports no new findings.

This article discusses interventions for female pattern hair loss but provides no new research findings.

This review discusses the role of histone deacetylases in hearing loss, proposing potential pharmacological interventions, but reports no new clinical results.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

This study reports that the prevalence of male pattern baldness in Asians is higher than previously believed, with potential links to socioeconomic factors and westernized diets, though the exact cause remains unclear.

This article discusses how the diagnosis and management of alopecia differ significantly between adults and children, emphasizing age-specific approaches but reports no new clinical findings.

This article reports the first documented cases of Marie-Unna hereditary hypotrichosis in Egypt, highlighting the variability of genetic mutations in this rare form of congenital hair loss.

This study found that the prevalence of male pattern baldness in the Asian population in Bangkok is higher than previously thought, approaching rates seen in Caucasians.

This article outlines management guidelines for androgenetic alopecia, highlighting that continued treatment with medications like finasteride or minoxidil typically halts progression and improves hair condition in most mild to moderate cases.

This review highlights that frontal fibrosing alopecia’s increasing incidence may involve immune, genetic, hormonal, and environmental factors, yet its pathogenesis remains complex and not fully understood.

In this study, researchers observed that men with androgenetic alopecia had a higher prevalence of metabolic syndrome compared to those without alopecia, which may warrant early screening for metabolic syndrome to prevent coronary artery disease, despite the study's small sample size.

This review concluded that oral finasteride for men and topical minoxidil for both genders have the most evidence supporting their effectiveness and safety for treating androgenetic alopecia.

This article highlights a specific, yet largely unrecognized, sign that aids in diagnosing androgenetic alopecia in women, emphasizing its practical application in clinical settings.

This article discusses various mechanisms for promoting hair growth in pattern hair loss and highlights the challenge of balancing short-term measurable results in trials with the need for long-term efficacy data.

This review discusses the psychological impact of alopecia on women and reports no new clinical findings, highlighting the effect on self-esteem and quality of life.

In this study, minoxidil treatment was associated with an increase in nonvellus scalp hairs, but this effect was not sustained once the treatment was stopped.

This study outlines the clinical features of androgenetic alopecia in Korean adolescents, finding milder symptoms compared to adults and a high occurrence of family history, with normal hormone levels.

This study found that loss of contact between the arrector pili muscle and the hair follicle bulge may explain why hair loss in male and female pattern baldness is largely irreversible, unlike in alopecia areata.

This systematic review study found that platelet-rich plasma treatment may improve hair density and diameter in women with androgenetic alopecia, although the findings are limited by the small sample sizes and pilot nature of the included studies.